Evidence map›Paper›PMID 32570810›Full record

ArticleGenes2020

Rapid Direct Nucleic Acid Amplification Test without RNA Extraction for SARS-CoV-2 Using a Portable PCR Thermocycler.

Soon Keong Wee, Suppiah Paramalingam Sivalingam, Eric Peng Huat Yap

Open access · goldAbstract read
In one paragraph

Article in Genes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 3 pooled it
2.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 3 syntheses or guidelines pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Multiplex on-chip detection ofFrontiers in bioengineering and biotechnology · 2026
    Article
  5. Article
  6. Utility of Protein Markers in COVID-19 Patients.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Digital PCR using a simple PDMS microfluidic chip and standard laboratory equipment.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Soon Keong WeeLee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.ORCID 0000-0002-8800-5134
Suppiah Paramalingam SivalingamLee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.ORCID 0000-0003-0238-133X
Eric Peng Huat YapLee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.
Nanyang Technological University · SG

Funding

Lee Kong Chian School of Medicine, Nanyang Technological University Eric Peng Huat Yap Start-Up GrantNational Research Foundation Singapore Eric Peng Huat Yap CRP13-2014-01
6 · The paper itself

Abstract

There is an ongoing worldwide coronavirus disease 2019 (Covid-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). At present, confirmatory diagnosis is by reverse transcription polymerase chain reaction (RT-PCR), typically taking several hours and requiring a molecular laboratory to perform. There is an urgent need for rapid, simplified, and cost-effective detection methods. We have developed and analytically validated a protocol for direct rapid extraction-free PCR (DIRECT-PCR) detection of SARS-CoV-2 without the need for nucleic acid purification. As few as six RNA copies per reaction of viral nucleocapsid (N) gene from respiratory samples such as sputum and nasal exudate can be detected directly using our one-step inhibitor-resistant assay. The performance of this assay was validated on a commercially available portable PCR thermocycler. Viral lysis, reverse transcription, amplification, and detection are achieved in a single-tube homogeneous reaction within 36 min. This minimizes hands-on time, reduces turnaround-time for sample-to-result, and obviates the need for RNA purification reagents. It could enable wider use of Covid-19 testing for diagnosis, screening, and research in countries and regions where laboratory capabilities are limiting.

Indexed as

BetacoronavirusCoronavirus InfectionsCOVID-19Exudates and TransudatesHumansLimit of DetectionNucleocapsidPandemicsPneumonia, ViralPoint-of-Care SystemsPolymerase Chain ReactionRNA, ViralSARS-CoV-2SputumRNA, ViralCovid-19DiagnosticsDIRECT-PCRPoint-of-careportable PCRSARS-CoV-2

Identifiers

PMID32570810
PMCPMC7349311
OpenAlexW3036487320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.